| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.00096 | 1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.00072 | 1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.0035 | 1 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.00043 | 1 |